Trump signs Most Favored Nation drug pricing executive order targeting pharmaceutical manufacturers

President Trump signs the Delivering Most-Favored Nation Prescription Drug Pricing to American Patients executive order, directing pharmaceutical manufacturers to offer the US the lowest price they charge any comparably developed foreign country for the same drugs. The order begins months of White House negotiations with major drug companies. On September 30, Pfizer becomes the first company to strike a deal, agreeing to provide state Medicaid programs with MFN prices and offer discounts on select top-selling drugs through a new federal platform called TrumpRx.